RipE1 undergoes phosphorylation in <i>N. benthamiana</i>, which contributes to protein stability. by Wenjia Yu (9422059)

RipE1 phosphorylation and NbUCH-mediated deubiquitination are independent mechanisms leading to RipE1 stability. by Wenjia Yu (9422059)

NbUCH15 promotes RipE1 stability by deubiquitination. by Wenjia Yu (9422059)

NbUCH positive regulates RipE1 accumulation in <i>N. benthamiana.</i> by Wenjia Yu (9422059)

RipE1 interacts with NbUCH12 and NbUCH15. by Wenjia Yu (9422059)

Silencing <i>NbUCHs</i> triggers SGT1-dependent immunity in <i>N. benthamiana.</i> by Wenjia Yu (9422059)

Matrix showing the percentage of identity between UCH proteins in <i>N. benthamiana. </i> by Wenjia Yu (9422059)

Few-Shot Symbol Detection in Engineering Drawings by Laura Jamieson (19759235)

“…The results suggest that our method not only significantly improves symbol detection performance compared to other state-of-the-art methods but also decreases the necessary number of training instances.…”

Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

CRISPR-Cas9-mediated mutation analysis of T₀ Stmc7 mutants. by Bikram Poudel (15989201)

Proposed model of apoptotic-like programmed cell death (AL-PCD) in plants. by Bikram Poudel (15989201)

Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

CONSORT diagram illustrating patient flow during the study. by Káryta Suely Macêdo Martins (22404155)

Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

Variables obtained from the SF-36 quality of life questionnaire in each experimental group. by Káryta Suely Macêdo Martins (22404155)

Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models. by Káryta Suely Macêdo Martins (22404155)